Eton Pharmaceuticals, Inc. business relationships
Companies named in Eton Pharmaceuticals, Inc.’s 10-K filed 2026-03-19, and public companies whose annual reports name Eton Pharmaceuticals, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.5 / 10
- AI naming
- <1 / 100 Top 55% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Eton Pharmaceuticals, Inc.’s annual report 2
“During the twelve months ended December 31, 2025, the Company recognized $ 5,094 in inventory step-up expense associated with the inventory purchase from Ipsen S.A.” SEC filing
“In March 2025, the Company out-licensed the commercial rights to INCRELEX® in territories outside of the U.S. to Esteve Pharmaceuticals, S.A. ("Esteve").” SEC filing
Companies whose annual reports name Eton Pharmaceuticals, Inc. 1
“License and Supply Agreement with Eton Pharmaceuticals, Inc.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.